$1.23-0.11 (-7.89%)
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets synthetic, biological, and biorational products for agricultural, commercial, and consumer uses in the United States and internationally.
American Vanguard Corporation in the Basic Materials sector is trading at $1.22 with a market capitalization of $64M. The stock is currently near its 52-week low of $1.19, remaining 59.7% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 0 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $116.75Mβ | $123.57Mβ | $150.69Mβ | $119.31Mβ | $129.31M |
| Gross Profit | $34.71Mβ | $38.42Mβ | $42.61Mβ | $34.21Mβ | $40.55M |
| Operating Income | $1.70Mβ | $2.63Mβ | $7.95Mβ | $1.81Mβ | $6.27M |
| Net Income | -$9.87Mβ | -$4.14Mβ | -$28.21Mβ | -$12.36Mβ | -$849,000 |
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets synthetic, biological, and biorational products for agricultural, commercial, and consumer uses in the United States and internationally. The company synthes...